Restricted accessResearch articleFirst published online 2021-06
Hypoglycemia Induces Mitochondrial Reactive Oxygen Species Production Through Increased Fatty Acid Oxidation and Promotes Retinal Vascular Permeability in Diabetic Mice
Hypoglycemia is associated with increased reactive oxygen species (ROS) production and vascular events. We have previously reported that low-glucose (LG) conditions induce mitochondrial ROS (mtROS) production in aortic endothelial cells (ECs). However, the mechanism by which hypoglycemia promotes diabetic retinopathy (DR) is unclear. Blood-retinal barrier (BRB) disruption occurs in the early stages of DR. We hypothesized that the mechanisms underlying hypoglycemia-induced DR are associated with BRB breakdown due to mtROS generation during hypoglycemia. Here, we aimed to determine whether hypoglycemia exacerbated mtROS production and induced BRB disruption.
Results:
We observed that hypoglycemia induced mtROS production by increasing fatty acid oxidation (FAO), which was suppressed by overexpression of mitochondrial-specific manganese superoxide dismutase (MnSOD) in retinal ECs. Furthermore, FAO blockade decreased the hypoglycemia-induced mtROS production. Recurrent hypoglycemia increased albumin leak in diabetic mice retina, which was suppressed in diabetic vascular endothelial cell-specific MnSOD transgenic (eMnSOD-Tg) mice. Pharmacological FAO blockade also reduced mtROS production, reduced vascular endothelial growth factor (VEGF) production during hypoglycemia, and prevented retinal vascular permeability in diabetic mice. MnSOD overexpression or carnitine palmitoyltransferase I (CPT1) blockade suppressed vascular endothelial-cadherin phosphorylation under LG in retinal ECs.
Innovation and Conclusion:
Reduction of mtROS and VEGF production via pharmacological FAO and/or CPT1 blockade may prevent hypoglycemia-induced worsening of DR.
Get full access to this article
View all access options for this article.
References
1.
Action to Control Cardiovascular Risk in Diabetes StudyGroup, GersteinHC, MillerME, ByingtonRP, GoffDCJr., BiggerJT, BuseJB, CushmanWC, GenuthS, Ismail-BeigiF, GrimmRHJr., ProbstfieldJL, Simons-MortonDG, and FriedewaldWT.Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med, 358: 2545–2559, 2008.
2.
American Diabetes Association. Physical activity/exercise and diabetes. Diabetes Care, 27: S58–62, 2004.
3.
AonMA, BhattN, and CortassaSC. Mitochondrial and cellular mechanisms for managing lipid excess. Front Physiol, 5: 282, 2014.
4.
AonMA, TocchettiCG, BhattN, PaolocciN, and CortassaS. Protective mechanisms of mitochondria and heart function in diabetes. Antioxid Redox Signal, 22: 1563–1586, 2015.
5.
BehlT and KotwaniA. Exploring the various aspects of the pathological role of vascular endothelial growth factor (VEGF) in diabetic retinopathy. Pharmacol Res, 99: 137–148, 2015.
6.
BriantLJB, DoddMS, ChibalinaMV, RorsmanNJG, JohnsonPRV, CarmelietP, RorsmanP, and KnudsenJG. CPT1a-dependent long-chain fatty acid oxidation contributes to maintaining glucagon secretion from pancreatic islets. Cell Rep, 23: 3300–3311, 2018.
7.
BrownleeM.Biochemistry and molecular cell biology of diabetic complications. Nature, 414: 813–820, 2001.
8.
ByeonSH, ChungHY, and KwonOW. Polyunsaturated fatty acid composition of surgically removed hard exudates in diabetic macular edema. Ophthalmic Surg Lasers Imaging, 9: 1–3, 2010.
CheungN, MitchellP, and WongTY. Diabetic retinopathy. Lancet, 376: 124–136, 2010.
11.
Cunha-VazJ, Faria de AbreuJR, and CamposAJ. Early breakdown of the blood-retinal barrier in diabetes. Br J Ophthalmol, 59: 649–656, 1975.
12.
Cunha-VazJG, FonsecaJR, AbreuJF, and RuasMA. A follow-up study by vitreous fluorophotometry of early retinal involvement in diabetes. Am J Ophthalmol, 86: 467–473, 1978.
13.
DantzD, BewersdorfJ, Fruehwald-SchultesB, KernW, JelkmannW, BornJ, FehmHL, and PetersA. Vascular endothelial growth factor: a novel endocrine defensive response to hypoglycemia. J Clin Endocrinol Metab, 87: 835–840, 2002.
14.
DejanaE, OrsenigoF, and LampugnaniMG. The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci, 121: 2115–2122, 2008.
15.
DesouzaCV, BolliGB, and FonsecaV. Hypoglycemia, diabetes, and cardiovascular events. Diabetes Care, 33: 1389–1394, 2010.
16.
DialloAM, NovellaJL, LukasC, SouchonPF, DraméM, FrançoisM, DecoudierB, BarraudS, SalmonAS, AncelleD, ArndtC, and DelemerB. Early predictors of diabetic retinopathy in type 1 diabetes: the Retinopathy Champagne Ardenne Diabète (ReCAD) study. J Diabetes Complications, 32: 753–758, 2018.
17.
DuckworthW, AbrairaC, MoritzT, RedaD, EmanueleN, ReavenPD, ZieveFJ, MarksJ, DavisSN, HaywardR, WarrenSR, GoldmanS, McCarrenM, VitekME, HendersonWG, HuangGD, and VADTInvestigators. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med, 360: 129–139, 2009.
18.
EllisEA, GrantMB, MurrayFT, WachowskiMB, GuberskiDL, KubilisPS, and LuttyGA. Increased NADH oxidase activity in the retina of the BBZ/Wor diabetic rat. Free Radic Biol Med, 24: 111–120, 1998.
FenerciogluAK, SalerT, GencE, SabuncuH, AltuntasY. The effects of polyphenol-containing antioxidants on oxidative stress and lipid peroxidation in type 2 diabetes mellitus without complications. J Endocrinol Invest, 33: 118–124, 2010.
24.
GavardJ and GutkindJS. VEGF controls endothelial-cell permeability by promoting the beta-arrestin-dependent endocytosis of VE-cadherin. Nat Cell Biol, 8: 1223–1234, 2006.
25.
GotoH, NishikawaT, SonodaK, KondoT, KukidomeD, FujisawaK, YamashiroT, MotoshimaH, MatsumuraT, TsuruzoeK, and ArakiE. Endothelial MnSOD overexpression prevents retinal VEGF expression in diabetic mice. Biochem Biophys Res Commun, 366: 814–820, 2008.
26.
HernándezC, BogdanovP, CorralizaL, García-RamírezM, Solà-AdellC, ArranzJA, ArrobaAI, ValverdeAM, and SimóR. Topical administration of GLP-1 receptor agonists prevents retinal neurodegeneration in experimental diabetes. Diabetes, 65: 172–187, 2016.
27.
HögbergH, EngblomL, EkdahlA, LidellV, WalumE, AlbertsP. Temperature dependence of O2 consumption; opposite effects of leptin and etomoxir on respiratory quotient in mice. Obesity (Silver Spring), 14: 673–682, 2006.
28.
KajiharaN, KukidomeD, SadaK, MotoshimaH, FurukawaN, MatsumuraT, NishikawaT, and ArakiE. Low glucose induces mitochondrial reactive oxygen species via fatty acid oxidation in bovine aortic endothelial cells. J Diabetes Investig, 8: 750–761, 2017.
29.
KanwarM, ChanPS, KernTS, and KowluruRA. Oxidative damage in the retinal mitochondria of diabetic mice: possible protection by superoxide dismutase. Invest Ophthalmol Vis Sci, 48: 3805–3811, 2007.
30.
KernTS.Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy. Exp Diabetes Res, 2007: 95103, 2007.
31.
KowluruRA, TangJ, and KernTS. Abnormalities of retinal metabolism in diabetes and experimental galactosemia. VII. Effect of long-term administration of antioxidants on the development of retinopathy. Diabetes, 50: 1938–1942, 2001.
32.
KumarB, KowluruA, and KowluruRA. Lipotoxicity augments glucotoxicity-induced mitochondrial damage in the development of diabetic retinopathy. Invest Ophthalmol Vis Sci, 56: 2985–2992, 2015.
33.
LeowMK and WyckoffJ. Under-recognised paradox of neuropathy from rapid glycaemic control. Postgrad Med J, 81: 103–107, 2005.
34.
MamputuJC and RenierG. Advanced glycation end products increase, through a protein kinase C-dependent pathway, vascular endothelial growth factor expression in retinal endothelial cells. Inhibitory effect of gliclazide. J Diabetes Complications, 16: 284–293, 2002.
35.
NishikawaT, EdelsteinD, DuXL, YamagishiS, MatsumuraT, KanedaY, YorekMA, BeebeD, OatesPJ, HammesHP, GiardinoI, and BrownleeM. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature, 404: 787–790, 2000.
36.
OhkuboY, KishikawaH, ArakiE, MiyataT, IsamiS, MotoyoshiS, KojimaY, FuruyoshiN, and ShichiriM. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract, 28: 103–117, 1995.
37.
RajagopalR, BligardGW, ZhangS, YinL, LukasiewiczP, and SemenkovichCF. Functional deficits precede structural lesions in mice with high-fat diet-induced diabetic retinopathy. Diabetes, 65: 1072–1084, 2016.
38.
SadaK, NishikawaT, KukidomeD, YoshinagaT, KajiharaN, SonodaK, SenokuchiT, MotoshimaH, MatsumuraT, and ArakiE. hyperglycemia induces cellular hypoxia through production of mitochondrial ROS followed by suppression of aquaporin-1. PLoS One, 11: e0158619, 2016.
39.
SahaAK, RudermanNB. Malonyl-CoA and AMP-activated protein kinase: an expanding partnership. Mol Cell Biochem, 253: 65–70, 2003.
40.
SchoorsS, BruningU, MissiaenR, QueirozKC, BorgersG, EliaI, ZecchinA, CantelmoAR, ChristenS, GoveiaJ, HeggermontW, GoddéL, VinckierS, Van VeldhovenPP, EelenG, SchoonjansL, GerhardtH, DewerchinM, BaesM, De BockK, GhesquièreB, LuntSY, FendtSM, and CarmelietP. Fatty acid carbon is essential for dNTP synthesis in endothelial cells. Nature, 520: 192–197, 2015.
41.
SinghP, JainA, and KaurG. Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage. Mol Cell Biochem, 26: 153–159, 2004.
42.
StaigerK, StaigerH, WeigertC, HaasC, HäringHU, and KellererM. Saturated, but not unsaturated, fatty acids induce apoptosis of human coronary artery endothelial cells via nuclear factor-kappaB activation. Diabetes, 55: 3121–3126, 2006.
43.
TanakaS, KawasakiR, Tanaka-MizunoS, IimuroS, MatsunagaS, MoriyaT, IshibashiS, KatayamaS, OhashiY, AkanumaY, SoneH, YamashitaH, and Japan Diabetes Complications StudyGroup. Severe hypoglycaemia is a major predictor of incident diabetic retinopathy in Japanese patients with type 2 diabetes. Diabetes Metab, 43: 424–429, 2017.
44.
The Diabetes Control and Complications Trial Research Group. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes, 44: 968–983, 1995.
45.
TikhonenkoM, LydicTA, WangY, ChenW, OpreanuM, SochackiA, McSorleyKM, RenisRL, KernT, JumpDB, ReidGE, and BusikJV. Remodeling of retinal fatty acids in an animal model of diabetes: a decrease in long-chain polyunsaturated fatty acids is associated with a decrease in fatty acid elongases Elovl2 and Elovl4. Diabetes, 59: 219–227, 2010.
TzengTF, HongTY, TzengYC, LiouSS, and LiuIM. Consumption of polyphenol-rich Zingiber zerumbet rhizome extracts protects against the breakdown of the blood-retinal barrier and retinal inflammation induced by diabetes. Nutrients, 7: 7821–7841, 2015.
48.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352: 837–853, 1998.
49.
United Kingdom Prospective Diabetes Study Group. United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy. Ann Intern Med, 128: 165–175, 1998.
50.
Weightman PotterPG, Vlachaki WalkerJM, RobbJL, ChiltonJK, WilliamsonR, RandallAD, EllacottKLJ, and BeallC. Basal fatty acid oxidation increases after recurrent low glucose in human primary astrocytes. Diabetologia, 62: 187–198, 2019.
YaffeK, FalveyCM, HamiltonN, HarrisTB, SimonsickEM, StrotmeyerES, ShorrRI, MettiA, SchwartzAV, and Health ABCStudy. Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus. JAMA Intern Med, 173: 1300–1306, 2013.
54.
YamagishiS, YonekuraH, YamamotoY, KatsunoK, SatoF, MitaI, OokaH, SatozawaN, KawakamiT, NomuraM, and YamamotoH. Advanced glycation end products-driven angiogenesis in vitro. Induction of the growth and tube formation of human microvascular endothelial cells through autocrine vascular endothelial growth factor. J Biol Chem, 272: 8723–8730, 1997.
55.
YaoH, GongJ, PetersonAL, LuX, ZhangP, and DenneryPA. Fatty acid oxidation protects against hyperoxia-induced endothelial cell apoptosis and lung injury in neonatal mice. Am J Respir Cell Mol Biol, 60: 667–677, 2019.
56.
ZoungasS, PatelA, ChalmersJ, de GalanBE, LiQ, BillotL, WoodwardM, NinomiyaT, NealB, MacMahonS, GrobbeeDE, KengneAP, MarreM, HellerS, and ADVANCE CollaborativeGroup. Severe hypoglycemia and risks of vascular events and death. N Engl J Med, 363: 1410–1418, 2010.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
